Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04461808 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tomosynthesis as Primary Test for Breast Cancer Screening

Study acronym: MAITA
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jul 15, 2019 to Mar 1, 2019
    • Collaborators shortened, about 15 words
    v4
  2. Site details revised at 1 of 4 sitesv3
  3. Primary completion date: Jun 30, 2024 to Apr 30, 2027v2 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 8000 to confirmed 10156
    • Study completion date: Jun 30, 2026 to Apr 30, 2029
    • Site details revised at 4 of 4 sites
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Randomized trial comparing tomosynthesis plus synthetic 2D Mammography vs Digital Mammography in respect to incidence of advanced cancers (interval and following round) and interval cancers.
Trial Details
NCT Number NCT04461808
Lead Sponsor Azienda USL Reggio Emilia - IRCCS
Conditions
(from sponsor)		 Breast Cancer
Related terms Breast Neoplasms
Enrollment 10,156 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov